AMERICAN SOCIETY OF GENE AND CELL THERAPY
20800 Swenson Dr 300, Waukesha, WI 53018 www.asgct.org

Total Revenue
$6,509,265
Total Expenses
$4,691,842
Net Assets
$8,301,637

Organizations Filed Purposes: ASGCT's mission is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease.

Annual Meeting: This is the Primary Vehicle for Carrying out the Educational Mission of ASGCT. The Annual Meeting Represents the Major Educational Initiative of the Society.

Other programs include: Gene Editing Workshop, Cell Therapy Workshop, Commercialization Workshop, Clinical Trials Training Course, Policy Summit, Career Development Program, Patient Education Program, and the Newsletter.

Molecular Therapy Journals: Publishing scholarly journals is the second major vehicle for carrying out the educational mission of ASGCT. The journals are the way ASGCT educates and updates researchers, clinicians, and students on the latest advances in the development of novel therapeutics.

Executives Listed on Filing

Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing

NameTitleHours Per WeekTotal Salary
Paloma H Giangrande PhdDirector3$3,720
Beverly Davidson PhdVice President5$3,375
Isabelle M Riviere PhdDirector3$1,400
Paula M Cannon PhdTreasurer5$0
Guangping Gao PhdPresident5$0
Richard Morgan PhdDirector3$0
J Keith Joung Md PhdDirector3$0
Stephen L Hart PhdDirector3$0
Seppo Yla-Herttuala Md PhdEx-Officio3$0
Terrence R Flotte MdSecretary5$0
Maritza Mcintyre PhdDirector3$0
Philip Gregory DphilDirector3$0
Jennifer E Adair PhdDirector3$0
Matthew Wilson Md PhdDirector3$0
Stephen J Russell Md PhdPresident-Elect5$0

Data for this page was sourced from XML published by IRS (public 990 form dataset) from: https://s3.amazonaws.com/irs-form-990/202043189349308149_public.xml